Lymphoid B cells induce NF-κB activation in high endothelial cells from human tonsils

International Immunology

Volumn 18, Issue 2, 2006, Pages 259-267

  Naves, Rodrigo ^a,d   Reyes, Lilian I ^c,d   Rosemblatt, Mario ^c,d   Jacobelli, Sergio ^a   González, Alfonso ^a,b,d   Bono, María R ^c,d  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

^d UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

Cytokines; Endothelial activation; High Endothelium; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PROTEIN P50; SALICYLATE SODIUM; SYNAPTOTAGMIN;

ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL ADHESION; CELL CONTACT; CELL INTERACTION; CELL NUCLEUS; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DAUDI CELL; ENDOTHELIUM CELL; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TONSIL CELL; WESTERN BLOTTING;

B-LYMPHOCYTES; COCULTURE TECHNIQUES; CYTOKINES; ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE ACTIVATION; NF-KAPPA B; RNA, MESSENGER; TONSIL; TUMOR CELLS, CULTURED;

EID: 31544481216     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxh365     Document Type: Article

References (44)

1. Cines, D. B., Pollak, E. S., Buck, C. A. et al. 1998. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527.
2. Osborn, L. 1990. Leukocyte adhesion to endothelium in inflammation. Cell 62:3.
3. Ebnet, K., Kaldjian, E. P., Anderson, A. O. and Shaw, S. 1996. Orchestrated information transfer underlying leukocyte endothelial interactions. Annu. Rev. Immunol. 14: 155.
4. Bevilacqua, M. P. 1993. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 11:767.
5. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76:301.
6. Springer, T. A. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57:827.
7. Butcher, E. C. and Picker, L. J. 1996. Lymphocyte homing and homeostasis. Science 272:60.
8. Girard, J. P. and Springer, T. A. 1995. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol. Today 16:449.
9. De Martin, R., Hoeth, M., Hofer-Warbinek, R. and Schmid, J. A. 2000. The transcription factor NF-kappa B and the regulation of vascular cell function. Arterioscler. Thromb. Vasc. Biol. 20:E83.
10. Baldwin, A. S., Jr. 1996. The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu. Rev. Immunol. 14:649.
11. May, M. J. and Ghosh, S. 1998. Signal transduction through NF-kappa B. Immunol. Today 19:80.
12. Montgomery, K. F., Osborn, L., Hession, C. et al. 1991. Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc. Natl Acad. Sci. USA 88:6523.
13. Collins, T., Read, M. A., Neish, A. S., Whitley, M. Z., Thanos, D. and Maniatis, T. 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9:899.
14. Neish, A. S., Williams, A. J., Palmer, H. J., Whitley, M. Z. and Collins, T. 1992. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J. Exp. Med. 176:1583.
15. Iademarco, M. F., McQuillan, J. J., Rosen, G. D. and Dean, D. C. 1992. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267:16323.
16. Nakayama, K., Shimizu, H., Mitomo, K., Watanabe, T., Okamoto, S. and Yamamoto, K. 1992. A lymphoid cell-specific nuclear factor containing c-Rel-like proteins preferentially interacts with interleukin-6 kappa B-related motifs whose activities are repressed in lymphoid cells. Mol. Cell. Biol. 12:1736.
17. Mukaida, N., Mahe, Y. and Matsushima, K. 1990. Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J. Biol. Chem. 265:21128.
18. Ueda, A., Ishigatsubo, Y., Okubo, T. and Yoshimura, T. 1997. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J. Biol. Chem. 272:31092.
19. Castro, A., Bono, M. R., Simon, V. and Rosemblatt, M. 1996. Lymphocyte adhesion to endothelium derived from human lymphoid tissue. Eur. J. Cell Biol. 70:61.
20. Reyes, L. I., Escobar, P., Bono, M. R. and Rosemblatt, M. 2002. Adhesion of B cell lines to endothelial cells from human lymphoid tissue modulates tyrosine phosphorylation and endothelial cell activation. J. Immunol. 169:5881.
21. Bono, R., Hyafil, F., Kalil, J. et al. 1979. Monoclonal antibodies against HLA-DRw antigens. Transplant. Clin. Immunol. 11:109.
22. Burgos, P., Metz, C., Bull, P. et al. 2000. Increased expression of c-Rel, from the NF-kappaB/Rel family, in T cells from patients with systemic lupus erythematosus. J. Rheumatol. 27:116.
23. Green, V. L., Atkin, S. L., Speirs, V. et al. 1996. Cytokine expression in human anterior pituitary adenomas. Clin. Endocrinol. (Oxf.) 45:179.
24. Chang, C. H., Fontes, J. D., Peterlin, M. and Flavell, R. A. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367.
25. Jeffes, E. W., III, Schmitz, K., Yamamoto, R. et al. 1991. A simple nonisotopic in vitro bioassay for LT and TNF employing sodium fluoride-treated L-929 target cells that detects picogram quantities of LT and TNF and is as sensitive as TNF assays done with ELISA methodology. Lymphokine Cytokine Res. 10:147.
26. Anrather, J., Csizmadia, V., Brostjan, C., Soares, M. P., Bach, F. H. and Winkler, H. 1997, Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B. J. Clin. Invest. 99:763.
27. Read, M. A., Whitley, M. Z., Williams, A. J. and Collins, T. 1994. NF-kappa B and I kappa B alpha: An inducible regulatory system in endothelial activation. J. Exp. Med. 179:503.
28. Read, M. A., Neish, A. S., Luscinskas, F. W., Palombella, V. J., Maniatis, T. and Collins, T. 1995. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 2:493.
29. Thompson, M. P., Aggarwal, B. B., Shishodia, S., Estrov, Z. and Kurzrock, R. 2003. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: Induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1. Leukemia 17:2196.
30. Kopp, E. and Ghosh, S. 1994. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265:956.
31. Pierce, J. W., Read, M. A., Ding, H., Luscinskas, F. W. and Collins, T. 1996. Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J. Immunol. 156:3961.
32. Baeuerle, P. A. and Henkel, T. 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:141.
33. Augustin, H. G., Kozian, D. H. and Johnson, R. C. 1994. Differentiation of endothelial cells: Analysis of the constitutive and activated endothelial cell phenotypes. Bioessays 16:901.
34. Risau, W. 1995. Differentiation of endothelium. FASEB J. 9:926.
35. Rajotte, D., Arap, W., Hagedorn, M., Koivunen, E., Pasqualini, R. and Ruoslahti, E. 1998. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J. Clin. Invest. 102:430.
36. Girard, J. P., Baekkevold, E. S., Yamanaka, T., Haraldsen, G., Brandtzaeg, P. and Amalric, F. 1999. Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization. Am. J. Pathol. 155:2043.
37. Oshima, T., Pavlick, K. P., Laroux, F. S. et al. 2001. Regulation and distribution of MAdCAM-1 in endothelial cells in vitro. Am. J. Physiol. Cell Physiol. 281:C1096.
38. Strasly, M., Cavallo, F., Geuna, M. et al. 2001. IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. J. Immunol. 166:3890.
39. Jarvis, L. J. and LeBien, T. W. 1995. Stimulation of human bone marrow stromal cell tyrosine kinases and IL-6 production by contact with B lymphocytes. J. Immunol. 155:2359.
40. Jarvis, L. J., Maguire, J. E. and LeBien, T. W. 1997. Contact between human bone marrow stromal cells and B lymphocytes enhances very late antigen-4/vascular cell adhesion molecule-1-independent tyrosine phosphorylation of focal adhesion kinase, paxillin, and ERK2 in stromal cells. Blood 90:1626.
41. Ramarli, D., Scupoli, M. T., Fiorini, E. et al. 1998. Thymocyte contact or monoclonal antibody-mediated clustering of 3beta1 or 6beta4 integrins activate interleukin-6 (IL-6) transcription factors (NF-kappaB and NF-IL6) and IL-6 production in human thymic epithelial cells. Blood 92:3745.
42. Scupoli, M. T., Fiorini, E., Marchisio, P. C. et al. 2000. Lymphoid adhesion promotes human thymic epithelial cell survival via NF-(kappa)B activation. J. Cell Sci. 113:169.
43. Cupedo, T. and Mebius, R. E. 2003. Role of chemokines in the development of secondary and tertiary lymphoid tissues. Semin. Immunol. 15:243.
44. Cupedo, T., Jansen, W., Kraal, G. and Mebius, R. E. 2004. Induction of secondary and tertiary lymphoid structures in the skin. Immunity 21:655.